Vectura Group (LSE:VEC)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VEC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VEC

  • Market Cap£611.370m
  • SymbolLSE:VEC
  • IndustryHealthcare
  • Sector-
  • Currency
  • ISINGB00BKM2MW97

Company Profile

Vectura Group PLC is engaged in inhaled product formulation, device design and development business offering an integrated inhaled drug delivery platform. The company has developed inhalation products to help patients suffering from airways diseases. It has approx ten key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. The company's partners include Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Bayer, Chiesi, Almirall, Dynavax and Tianjin KingYork. The company operates in the United Kingdom, Japan, Switzerland, the United States of America, and Rest of the world with maximum revenue from the United Kingdom.Vectura Group PLC is a respiratory product development company. It is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use.

Latest VEC news

Currently there for this company. Visit our news hub for other news .

VEC Regulatory news

Currently there for this company. Visit our news hub for other news .